Literature DB >> 9738910

Transport of amino acid aryl amides by the intestinal H+/peptide cotransport system, PEPT1.

V Börner1, Y J Fei, B Hartrodt, V Ganapathy, F H Leibach, K Neubert, M Brandsch.   

Abstract

Transport of amino acid aryl amides by the intestinal H+/peptide symporter (PEPT1) was studied in Caco-2 cells and in Xenopus laevis oocytes expressing human PEPT1. Several amino acid amides were able to inhibit the uptake of [14C]glycylsarcosine in Caco-2 cells. Ala-4-nitroanilide (Ki = 0.08 mM), Phe-4-nitroanilide (Ki = 0.09 mM) and Ala-4-phenylanilide (Ki = 0.03 mM) were accepted as substrates with equal or higher affinity than natural Ala-Xaa dipeptides. Ala-anilide (Ki = 2.9 mM), Ala-7-amido-4-methylcoumarin (Ki = 0.2 mM), Ala-4-chloroanilide (Ki = 0.3 mM) and Ala-4-methylanilide (Ki = 0.3 mM) were also recognized by PEPT1 as substrates. In contrast, alanine, Ala-amide, Phe-amide, Ala-methyl ester, Ala-4-nitrobenzyl ester and Ala-methylamide were not recognized (Ki > 20 mM). In X. laevis oocytes, transport of Ala-4-nitroanilide, Ala-7-amido-4-methylcoumarin, Ala-4-methylanilide and Ala-anilide was associated with transfer of positive charge and the currents were saturable with respect to substrate concentration (K0.5 values: 0.1, 0.2, 0.8 and 3.1 mM, respectively). The currents induced by Ala-4-methylanilide were saturable with respect to the substrate concentration and influenced by the membrane potential. The affinity of the transporter for Ala-4-methylanilide was also found to be influenced by the membrane potential. We conclude that the intestinal H+/peptide cotransport system PEPT1 accepts amino acid aryl amides as substrates.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9738910     DOI: 10.1046/j.1432-1327.1998.2550698.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  9 in total

Review 1.  Theoretical predictions of drug absorption in drug discovery and development.

Authors:  Patric Stenberg; Christel A S Bergström; Kristina Luthman; Per Artursson
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  Bioavailability through PepT1: the role of computer modelling in intelligent drug design.

Authors:  David W Foley; Jeyaganesh Rajamanickam; Patrick D Bailey; David Meredith
Journal:  Curr Comput Aided Drug Des       Date:  2010-03       Impact factor: 1.606

3.  Effects of glibenclamide on glycylsarcosine transport by the rat peptide transporters PEPT1 and PEPT2.

Authors:  K Sawada; T Terada; H Saito; Y Hashimoto; K Inui
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

Review 4.  Function, Regulation, and Pathophysiological Relevance of the POT Superfamily, Specifically PepT1 in Inflammatory Bowel Disease.

Authors:  Emilie Viennois; Adani Pujada; Jane Zen; Didier Merlin
Journal:  Compr Physiol       Date:  2018-03-25       Impact factor: 9.090

Review 5.  Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Microbiol Mol Biol Rev       Date:  2013-09       Impact factor: 11.056

6.  Kinetics and substrate specificity of membrane-reconstituted peptide transporter DtpT of Lactococcus lactis.

Authors:  G Fang; W N Konings; B Poolman
Journal:  J Bacteriol       Date:  2000-05       Impact factor: 3.490

7.  A charge pair interaction between Arg282 in transmembrane segment 7 and Asp341 in transmembrane segment 8 of hPepT1.

Authors:  Ashutosh A Kulkarni; Daryl L Davies; Jennifer S Links; Leena N Patel; Vincent H L Lee; Ian S Haworth
Journal:  Pharm Res       Date:  2006-09-29       Impact factor: 4.580

8.  Regulation of the oligopeptide transporter, PEPT-1, in DSS-induced rat colitis.

Authors:  Genia Radeva; Marion Buyse; Patrick Hindlet; Benjamin Beaufils; Francine Walker; André Bado; Robert Farinotti
Journal:  Dig Dis Sci       Date:  2007-03-20       Impact factor: 3.487

9.  Accurate Prediction of Ligand Affinities for a Proton-Dependent Oligopeptide Transporter.

Authors:  Firdaus Samsudin; Joanne L Parker; Mark S P Sansom; Simon Newstead; Philip W Fowler
Journal:  Cell Chem Biol       Date:  2016-01-28       Impact factor: 8.116

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.